RIYADH: South Korean SK Bioscience Company has topped the list of the world’s best-performing IPO in 2021 after raising more than $1 billion. The biopharmaceutical firm, which is a local COVID-19 vaccine production partner with AstraZeneca, led a ranking dominated by listings from its home country, according to an analysis by Bloomberg. The IPO raised $1.3 billion for SK Bioscience to become the first among five Korean firms that raised more than $1 billion each through public offerings this year, with several tech-related names also surging in their trading debuts, Bloomberg said. SK Bioscience outperformed two major listings in Shanghai, China Three Gorges Renewables Group and Zhuzhou CRRC Times Electric Co., which are each up more than 140 percent. US Affirm Holdings came fourth, followed by South Korean Kakao Pay, and India’s Zomato.